Orchid Pharma share price has plunged 4% and is presently trading at Rs 1,165.9.
Meanwhile, the BSE HEALTHCARE index is at 36,831.0 (up 0.4%).
Among the top losers in the BSE HEALTHCARE index today are POLY MEDICURE (down 3.6%) and HIKAL CHEMIC (down 3.1%).
CAPLIN POINT (up 7.3%) and SUVEN PHARMACEUTICALS (up 6.5%) are among the top gainers today.
Over the last one year, Orchid Pharma has moved up from Rs 498.4 to Rs 1,165.9, registering a gain of Rs 667.6 (up 134.0%).
On the other hand, the BSE HEALTHCARE index has moved up from 25,266.1 to 36,831.0, registering a gain of 45.8% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Cadila Healthcare (up 88.9%), Glenmark Pharma (up 88.9%) and GSK Pharma (up 87.4%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 79,245.0 (up 0.7%).
The top gainers among the BSE Sensex today are Ultratech Cement (up 5.3%) and NTPC (up 3.3%). The most traded stocks in the BSE Sensex are Tata Steel and Infosys.
In the meantime, NSE Nifty is at 24,036.1 (up 0.7%). Ultratech Cement and LTIMINDTREE are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 62,970.0 to 79,245.0, registering a gain of 16,275.0 points (up 25.8%).
Orchid Pharma net profit fell 49.2% YoY to Rs 335 million for the quarter ended March 2024, compared to a profit of Rs 659 million a year ago. Net sales rose 3.4% to Rs 2,171 million during the period as against Rs 2,099 million in January-March 2023.
For the year ended March 2023, Orchid Pharma reported 197.1% increase in net profit to Rs 552 million compared to net loss of Rs 569 million during FY22. Revenue of the company grew 19.0% to Rs 6,659 million during FY23.
The current Price to earnings ratio of Orchid Pharma, based on rolling 12 month earnings, stands at 62.6.
Equitymaster requests your view! Post a comment on "Orchid Pharma Plunges 4%; BSE HEALTHCARE Index Up 0.4%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!